Company Overview of NeuroGenetic Pharmaceuticals, Inc.
NeuroGenetic Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of drug therapies for use in the prevention and treatment of neurodegenerative disorders. It focuses on Alzheimer’s disease (AD) therapeutics. The company offers a patented technology of gamma-secretase modulators that alters the production of amyloid proteins from the toxic form found in AD brains to non-toxic forms, which do not contribute to plaque deposition. It has patents in the United States, India, China, Canada, Mexico, and internationally. The company was founded in 2009 and is based in Del Mar, California.
445 Marine View Avenue
Del Mar, CA 92014
Founded in 2009
Key Executives for NeuroGenetic Pharmaceuticals, Inc.
NeuroGenetic Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|Eve Biomedical, Inc.||United States|
|NeuroTrack Technologies, Inc.||United States|
|Parcell Laboratories, Inc.||United States|
|Star Biologics, Inc.||United States|
|Vicept Therapeutics Incorporated||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact NeuroGenetic Pharmaceuticals, Inc., please visit www.neurogeneticpharmaceuticals.com. Company data is provided by Capital IQ. Please use this form to report any data issues.